Inhibition of the Leucine-Rich Repeat Protein LINGO-1 Enhances Survival, Structure, and Function of Dopaminergic Neurons in Parkinson's Disease Models

The nervous system-specific leucine-rich repeat Ig-containing protein LINGO-1 is associated with the Nogo-66 receptor complex and is endowed with a canonical EGF receptor (EGFR)-like tyrosine phosphorylation site. Our studies indicate that LINGO-1 expression is elevated in the substantia nigra of Pa...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 104; no. 36; pp. 14430 - 14435
Main Authors Inoue, Haruhisa, Lin, Ling, Lee, Xinhua, Saho, Zhaohui, Mendes, Shannon, Snodgrass-Belt, Pamela, Sweigard, Harry, Engber, Tom, Pepinsky, Blake, Yang, Lichuan, Beal, M. Flint, Mi, Sha, Isacson, Ole
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 04.09.2007
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The nervous system-specific leucine-rich repeat Ig-containing protein LINGO-1 is associated with the Nogo-66 receptor complex and is endowed with a canonical EGF receptor (EGFR)-like tyrosine phosphorylation site. Our studies indicate that LINGO-1 expression is elevated in the substantia nigra of Parkinson's disease (PD) patients compared with age-matched controls and in animal models of PD after neurotoxic lesions. LINGO-1 expression is present in midbrain dopaminergic (DA) neurons in the human and rodent brain. Therefore, the role of LINGO-1 in cell damage responses of DA neurons was examined in vitro and in experimental models of PD induced by either oxidative (6-hydroxydopamine) or mitochondrial (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) toxicity. In LINGO-1 knockout mice, DA neuron survival was increased and behavioral abnormalities were reduced compared with WT. This neuroprotection was accompanied by increased Akt phosphorylation (p-Akt). Similar neuroprotective in vivo effects on midbrain DA neurons were obtained in WT mice by blocking LINGO-1 activity using LINGO-1-Fc protein. Neuroprotection and enhanced neurite growth were also demonstrated for midbrain DA neurons in vitro. LINGO-1 antagonists (LINGO-1-Fc, dominant negative LINGO-1, and anti-LINGO-1 antibody) improved DA neuron survival in response to MPP⁺ in part by mechanisms that involve activation of the EGFR/Akt signaling pathway through a direct inhibition of LINGO-1's binding to EGFR. These results show that inhibitory agents of LINGO-1 activity can protect DA neurons against degeneration and indicate a role for the leucine-rich repeat protein LINGO-1 and related classes of proteins in the pathophysiological responses of midbrain DA neurons in PD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: H.I. and L.L. contributed equally to this work; H.I., L.L., S.M., and O.I. designed research; H.I., L.L., X.L., Z.S., S.M., P.S.-B., H.S., T.E., B.P., and L.Y. performed research; X.L., Z.S., M.F.B., and S.M. contributed new reagents/analytic tools; H.I., L.L., Z.S., P.S.-B., S.M., and O.I. analyzed data; and H.I., L.L., S.M., and O.I. wrote the paper.
Edited by Tomas Hökfelt, Karolinska Institutet, Stockholm, Sweden, and approved July 22, 2007
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0700901104